Tirzepatide 2023788-19-2

Tirzepatide 2023788-19-2stands raws li lub ntiaj teb thawj "dual- phiaj" agonist muaj peev xwm ua rau tib lub sijhawm ua kom cov qabzib -dependent insulinotropic polypeptide (GIP) thiab glucagon-xws li peptide-1 (GLP-1) receptors, yog li ua kom muaj kev tswj xyuas cov tshuaj insulin ntau dua. Cov tshuaj no tau pom zoo rau kev kho mob ntshav qab zib hom 2, rau ntev - tswj qhov hnyav hauv cov neeg laus rog lossis rog rog, thiab rau kev kho mob rog uas nyuaj los ntawm qhov nruab nrab mus rau qhov hnyav obstructive pw tsaug zog apnea (OSA). Hauv kev sim tshuaj, Tirzepatide 2023788-19-2 qhov txiaj ntsig zoo tshaj plaws ntawm kev poob phaus thiab txo cov ntshav qabzib tau ua tau zoo tshaj ntawm cov tshuaj GLP-1 feem ntau; Txawm li cas los xij, cov neeg siv yuav tsum nco ntsoov cov lus ceeb toom txog cov kev mob tshwm sim hauv plab hnyuv nrog rau qhov tsis tshua muaj kev pheej hmoo ntawm thyroid C-cell qog.

1. Lub Ntiaj Teb No, Localized footprint
Tsav los ntawm kev tawg tawg hauv kev xav tau thoob ntiaj teb, Eli Lilly tau txais ib qho "ntiaj teb no ntau-site"Lub peev xwm layout lub tswv yim los txo cov kev pheej hmoo ntawm cov khoom lag luam cuam tshuam hauv ib cheeb tsam.

• Muaj zog nyob rau sab hnub poob: Hauv Indiana, Tebchaws Asmeskas, Eli Lilly tau cog lus rau keeb kwm $ 9 nphom kev nqis peev los nthuav nws cov chaw tsim khoom, feem ntau ua haujlwm rau nws cov lag luam tseem ceeb hauv North America thiab Europe.
• Kev nqis peev hnyav hauv Suav teb: Tsiv dhau nws txoj kev coj noj coj ua ntawm kev saib Tuam Tshoj nkaus xwb raws li kev lag luam muag, Eli Lilly tsis ntev los no tau tshaj tawm kev nqis peev ntawm $ 3 nphom hauv kaum xyoo tom ntej los nthuav nws cov khoom siv hauv lub tebchaws. Qhov kev tawm tswv yim no ua haujlwm rau ob lub hom phiaj: nws tsis tsuas yog pab tiv thaiv kev pheej hmoo ntawm geopolitical, tab sis nws tseem ua rau lub tuam txhab ze rau ib qho ntawm cov neeg siv khoom lag luam loj tshaj plaws hauv ntiaj teb.

2. Xi'an: Lub Hub Tshiab rau Inland Supply Chains
Rau cov chaw muag tshuaj hauv zos hauv Xi'an, tam sim no thoob ntiaj teb boom hauv peptide kho mob nthuav tawm cov sijhawm tsis tau muaj dua. Raws li ib tug loj biopharmaceutical hub nyob rau hauv Northwest Tuam Tshoj, Xi'an muaj cov nram qab no zoo:

• Raw Material Sourcing Advantage: Cov cheeb tsam nyob ib puag ncig Xi'an khav theeb kev lag luam ua lag luam rau cov amino acid derivatives thiab cov tshuaj zoo, muaj peev xwm muab cov khoom tseem ceeb ntawm cov dej pib pib-xws li tiv thaiv amino acids thiab resins-tseem ceeb rau peptide synthesis. Piv nrog rau thaj tsam ntug dej hiav txwv, cov lag luam hauv Xi'an txaus siab rau qhov txiaj ntsig zoo ntawm cov khoom lag luam thaum nrhiav cov khoom siv tshuaj lom neeg tshwj xeeb rau thaj tsam Northwest.
• Txoj Cai thiab Logistics: Leveraging Xi'an Chaw nres nkoj thiab "Chang'an" Tuam Tshoj-Europe Railway Express, kws tshuaj intermediates thiab APIs uas tsim nyob rau hauv Xi'an tuaj yeem thauj ncaj qha mus rau European kev lag luam, txiav lub sijhawm thauj mus los los ntawm kwv yees li 60% piv rau hiav txwv freight. Qhov txiaj ntsig ntawm txoj kev logistical no ua rau Xi'an-raws li cov tuam txhab lag luam sib tw thoob ntiaj teb thaum tswj hwm "cov qauv nqi hauv av."
• Talent Pas dej: Xi'an yog lub tsev rau ntau lub tsev kawm ntawv qib siab thiab cov chaw tshawb fawb, uas txhua xyoo kawm tiav ntau cov kws tshaj lij hauv chemistry thiab kws tshuaj. Qhov no muab lub pas dej ua ke ruaj khov thiab muaj peev xwm ua tau zoo rau siab -txoj kev siv thev naus laus zis, xws li peptide synthesis.

1. Kev lag luam Barriers
Cov peev txheej thiab peev txheej rau Tirzepatide 2023788-19-2 yog qhov tshwj xeeb. Cov txheej txheem ua tiav entails ib ntu ntawm cov kauj ruam-synthesis, cleavage, purification, thiab lyophilization-nrog rau ib lub voj voog ib lub voj voog hla ob peb lub lis piam. Noj 500-liter reactor ua piv txwv, qhov kawg tawm los tsuas yog kwv yees li1.5 kg ibntawm cov khoom tiav. Yog li ntawd, kev ua tiav kev lag luam muaj tseeb - teev cov khoom tsim nyog yuav tsum muaj cov khoom siv hluav taws xob ntau ntau thiab cov kab ntau lawm.

2.Our pob zeb muaj peev xwm ntau lawm
Leveraging Xi'an cov kev lag luam infrastructure thiab lub peev xwm pas dej ua ke- thiab kos raws li peb pab neeg uas nws kim heev, ntev - sawv kev txawj ntse nyob rau hauv ib tug ruaj khov-theem synthesis- peb tau tsim ib tug paub tab thiab robust ntau lawm system:

Peb qhov kev xa khoom zoo: Kev siv peb cov pab pawg hauv zos los muab kev txhawb nqa sai sai- ua ke nrog kev xa khoom tau zoo ntawm Tuam Tshoj -Europe Railway Express- peb ua kom cov khoom xa khoom tau zoo, yog li txhawb nqa peb cov neeg siv khoom los tuav txoj kev pib thaum muaj kev sib tw ua lag luam hnyav.

1. Core Strategy: Khoom -Kua Hybrid Synthesis

Kev lag luam adopts asolid{0}} kua hybrid synthesis method, uas tuaj yeem nkag siab tias "prefabricating modules ua ntej, tom qab ntawd sib sau ua ke tag nrho":

Cov khoom qub-theem txheej txheem: Ntxiv cov amino acids ib los ntawm ib qho zoo li tso cib. Qhov ntev ntawm cov saw, qhov ua haujlwm qis dua thiab ntau impurities.

Khoom - kua hybrid txoj kev: Ob peb luv peptide fragments yog synthesized nyias ua ntej, ces spliced ​​ua ke nyob rau hauv ib tug kua theem ib zaug. Qhov no ua rau lub voj voog tsim khoom luv dua thiab muaj txiaj ntsig ntau dua.

2. Purification: Ob-Keeb Rov Qab-Phase Chromatography

Cov peptide crude muaj impurities nrog cov qauv zoo sib xws, yuav tsum tau ua kom huv huv kom ua tau raws li cov qauv tshuaj - qib:

3. Tshaj tawm -Kev Kho Mob: Nanofiltration + Freeze-Kev ziab

Nanofiltration concentration: Maj mam tshem cov ntsev thiab cov kuab tshuaj organic, ua haujlwm zoo dua li cov tshuaj distillation

Txias- kom qhuav: Dehydrates ntawm qhov kub thiab txias kom tau txais cov hmoov dawb ruaj khov API

4. Peb Muaj Peev Xwm Txheej Txheem